MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration.
Cortical neurons
Endogenous Toll-like receptor ligands
Extracellular microRNAs
Microglia
Neurodegeneration
Neuronal apoptosis
miRNA microarray
Journal
Molecular neurodegeneration
ISSN: 1750-1326
Titre abrégé: Mol Neurodegener
Pays: England
ID NLM: 101266600
Informations de publication
Date de publication:
27 11 2021
27 11 2021
Historique:
received:
11
06
2021
accepted:
03
11
2021
entrez:
28
11
2021
pubmed:
29
11
2021
medline:
5
4
2022
Statut:
epublish
Résumé
MicroRNA (miRNA) expression in the brain is altered in neurodegenerative diseases. Recent studies demonstrated that selected miRNAs conventionally regulating gene expression at the post-transcriptional level can act extracellularly as signaling molecules. The identity of miRNA species serving as membrane receptor ligands involved in neuronal apoptosis in the central nervous system (CNS), as well as the miRNAs' sequence and structure required for this mode of action remained largely unresolved. Using a microarray-based screening approach we analyzed apoptotic cortical neurons of C56BL/6 mice and their supernatant with respect to alterations in miRNA expression/presence. HEK-Blue Toll-like receptor (TLR) 7/8 reporter cells, primary microglia and macrophages derived from human and mouse were employed to test the potential of the identified miRNAs released from apoptotic neurons to serve as signaling molecules for the RNA-sensing receptors. Biophysical and bioinformatical approaches, as well as immunoassays and sequential microscopy were used to analyze the interaction between candidate miRNA and TLR. Immunocytochemical and -histochemical analyses of murine CNS cultures and adult mice intrathecally injected with miRNAs, respectively, were performed to evaluate the impact of miRNA-induced TLR activation on neuronal survival and microglial activation. We identified a specific pattern of miRNAs released from apoptotic cortical neurons that activate TLR7 and/or TLR8, depending on sequence and species. Exposure of microglia and macrophages to certain miRNA classes released from apoptotic neurons resulted in the sequence-specific production of distinct cytokines/chemokines and increased phagocytic activity. Out of those miRNAs miR-100-5p and miR-298-5p, which have consistently been linked to neurodegenerative diseases, entered microglia, located to their endosomes, and directly bound to human TLR8. The miRNA-TLR interaction required novel sequence features, but no specific structure formation of mature miRNA. As a consequence of miR-100-5p- and miR-298-5p-induced TLR activation, cortical neurons underwent cell-autonomous apoptosis. Presence of miR-100-5p and miR-298-5p in cerebrospinal fluid led to neurodegeneration and microglial accumulation in the murine cerebral cortex through TLR7 signaling. Our data demonstrate that specific miRNAs are released from apoptotic cortical neurons, serve as endogenous TLR7/8 ligands, and thereby trigger further neuronal apoptosis in the CNS. Our findings underline the recently discovered role of miRNAs as extracellular signaling molecules, particularly in the context of neurodegeneration.
Sections du résumé
BACKGROUND
MicroRNA (miRNA) expression in the brain is altered in neurodegenerative diseases. Recent studies demonstrated that selected miRNAs conventionally regulating gene expression at the post-transcriptional level can act extracellularly as signaling molecules. The identity of miRNA species serving as membrane receptor ligands involved in neuronal apoptosis in the central nervous system (CNS), as well as the miRNAs' sequence and structure required for this mode of action remained largely unresolved.
METHODS
Using a microarray-based screening approach we analyzed apoptotic cortical neurons of C56BL/6 mice and their supernatant with respect to alterations in miRNA expression/presence. HEK-Blue Toll-like receptor (TLR) 7/8 reporter cells, primary microglia and macrophages derived from human and mouse were employed to test the potential of the identified miRNAs released from apoptotic neurons to serve as signaling molecules for the RNA-sensing receptors. Biophysical and bioinformatical approaches, as well as immunoassays and sequential microscopy were used to analyze the interaction between candidate miRNA and TLR. Immunocytochemical and -histochemical analyses of murine CNS cultures and adult mice intrathecally injected with miRNAs, respectively, were performed to evaluate the impact of miRNA-induced TLR activation on neuronal survival and microglial activation.
RESULTS
We identified a specific pattern of miRNAs released from apoptotic cortical neurons that activate TLR7 and/or TLR8, depending on sequence and species. Exposure of microglia and macrophages to certain miRNA classes released from apoptotic neurons resulted in the sequence-specific production of distinct cytokines/chemokines and increased phagocytic activity. Out of those miRNAs miR-100-5p and miR-298-5p, which have consistently been linked to neurodegenerative diseases, entered microglia, located to their endosomes, and directly bound to human TLR8. The miRNA-TLR interaction required novel sequence features, but no specific structure formation of mature miRNA. As a consequence of miR-100-5p- and miR-298-5p-induced TLR activation, cortical neurons underwent cell-autonomous apoptosis. Presence of miR-100-5p and miR-298-5p in cerebrospinal fluid led to neurodegeneration and microglial accumulation in the murine cerebral cortex through TLR7 signaling.
CONCLUSION
Our data demonstrate that specific miRNAs are released from apoptotic cortical neurons, serve as endogenous TLR7/8 ligands, and thereby trigger further neuronal apoptosis in the CNS. Our findings underline the recently discovered role of miRNAs as extracellular signaling molecules, particularly in the context of neurodegeneration.
Identifiants
pubmed: 34838071
doi: 10.1186/s13024-021-00498-5
pii: 10.1186/s13024-021-00498-5
pmc: PMC8626928
doi:
Substances chimiques
Ligands
0
MIRN298 microRNA, mouse
0
MicroRNAs
0
Toll-Like Receptor 7
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
80Informations de copyright
© 2021. The Author(s).
Références
Brain Res. 2019 Apr 1;1708:100-108
pubmed: 30552897
Nucleic Acids Res. 2015 Jan;43(Database issue):D146-52
pubmed: 25378301
Nat Immunol. 2002 Jun;3(6):499
pubmed: 12032557
J Immunol. 2004 Sep 15;173(6):3916-24
pubmed: 15356140
J Immunol. 2002 Jan 15;168(2):554-61
pubmed: 11777946
J Neurosci. 2002 Apr 1;22(7):2478-86
pubmed: 11923412
Cells. 2020 Jan 11;9(1):
pubmed: 31940779
Nat Commun. 2013;4:1562
pubmed: 23463005
JCI Insight. 2020 Apr 9;5(7):
pubmed: 32271161
J Neuropathol Exp Neurol. 2002 Nov;61(11):1013-21
pubmed: 12430718
Algorithms Mol Biol. 2011 Nov 24;6:26
pubmed: 22115189
Genome Res. 2009 Jan;19(1):92-105
pubmed: 18955434
Science. 2004 Mar 5;303(5663):1526-9
pubmed: 14976262
Nat Struct Mol Biol. 2015 Feb;22(2):109-15
pubmed: 25599397
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8514-9
pubmed: 12824464
Acta Neuropathol Commun. 2017 Jan 31;5(1):10
pubmed: 28137310
J Immunol. 2012 Feb 1;188(3):1098-107
pubmed: 22198949
Curr Opin Struct Biol. 2017 Dec;47:52-59
pubmed: 28600980
Microrna. 2013;2(1):14-9
pubmed: 25070711
J Immunol. 2012 Aug 1;189(3):1448-58
pubmed: 22745379
Mol Neurodegener. 2015 Feb 26;10:5
pubmed: 25887709
Nucleic Acids Res. 2008 Jan;36(Database issue):D149-53
pubmed: 18158296
Bioinformatics. 2007 Jan 15;23(2):257-8
pubmed: 17098774
Mol Ther Nucleic Acids. 2018 Sep 7;12:158-173
pubmed: 30195755
Ann Neurol. 1997 Feb;41(2):200-9
pubmed: 9029069
J Biol Chem. 2006 Dec 8;281(49):37427-34
pubmed: 17040905
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Immunity. 2016 Oct 18;45(4):737-748
pubmed: 27742543
Nat Genet. 2007 Oct;39(10):1278-84
pubmed: 17893677
Nat Immunol. 2010 May;11(5):373-84
pubmed: 20404851
J Immunol Methods. 2009 Mar 15;342(1-2):71-7
pubmed: 19135446
Drug Discov Today Dis Models. 2008;5(1):19-25
pubmed: 19444332
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
PLoS One. 2018 Jul 16;13(7):e0200602
pubmed: 30011310
J Neurosci. 2008 Mar 5;28(10):2320-31
pubmed: 18322079
Bioinformatics. 2010 Oct 1;26(19):2363-7
pubmed: 20688976
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):E2110-6
pubmed: 22753494
Immunity. 2016 Oct 18;45(4):705-707
pubmed: 27760331
Annu Rev Med. 2018 Jan 29;69:437-449
pubmed: 29106805
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Neuron. 2014 Apr 2;82(1):47-54
pubmed: 24698267
J Neurosci. 2007 Nov 21;27(47):13033-41
pubmed: 18032677
J Biol Chem. 2009 Jan 23;284(4):1971-81
pubmed: 18986979
Sci Rep. 2016 Oct 03;6:34512
pubmed: 27694855
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5598-603
pubmed: 15034168
Int J Biochem Mol Biol. 2012;3(4):365-73
pubmed: 23301201
PLoS One. 2015 May 20;10(5):e0126423
pubmed: 25992776
Cell Physiol Biochem. 2007;20(6):947-56
pubmed: 17982277
PLoS One. 2010 Oct 20;5(10):e13515
pubmed: 20976003
J Immunol. 2008 Mar 15;180(6):3729-38
pubmed: 18322178
Nat Neurosci. 2012 Jun;15(6):827-35
pubmed: 22610069
Nature. 2002 Jul 11;418(6894):191-5
pubmed: 12110890
Nucleic Acids Res. 2016 Jan 4;44(D1):D239-47
pubmed: 26590260
Blood. 2013 Jun 6;121(23):4663-71
pubmed: 23580661
J Virol. 2005 Oct;79(20):12893-904
pubmed: 16188991
Mol Psychiatry. 2020 Jan 15;:
pubmed: 31942037
Cell Rep. 2018 Dec 18;25(12):3371-3381.e5
pubmed: 30566863
Front Aging Neurosci. 2015 Nov 18;7:210
pubmed: 26635599
PLoS One. 2014 Aug 22;9(8):e101725
pubmed: 25148207
Cell Rep. 2019 Dec 10;29(11):3460-3471.e7
pubmed: 31825829
PLoS One. 2014 Nov 25;9(11):e113848
pubmed: 25423301
Trends Neurosci. 2020 Oct;43(10):822-838
pubmed: 32839001
Bio Protoc. 2016 Nov 5;6(21):
pubmed: 29104891
Acta Neuropathol. 2011 Feb;121(2):193-205
pubmed: 20936480
Nucleic Acids Res. 2011 Sep 1;39(16):7223-33
pubmed: 21609964
J Alzheimers Dis. 2008 May;14(1):27-41
pubmed: 18525125
Elife. 2015 Aug 12;4:
pubmed: 26267216